You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 2, February 1950 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TRYPARSAMIDE AND BISMUTH SUBSALICYLATE IN THE TREATMENT OF EXPERIMENTAL SYPHILIS OF RABBITS

Synergistic or Additive Activity

JOHN A. KOLMER, M.D.; ANNA M. RULE

Arch Derm Syphilol. 1950;61(2):271-275.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A COMBINATION of penicillin injected intramuscularly and oxophenarsine hydrochloride (mapharsen®) administered intravenously has shown pronounced synergistic or additive effects in the chemotherapy of acute syphilitic orchitis of rabbits.1 Similar results have been observed in combined treatment with penicillin and bismuth compounds administered intramuscularly.2 Synergistic or additive effects have been observed also in combined treatment with penicillin given orally and oxophenarsine hydrochloride injected intravenously and intramuscularly and bismuth subsalicylate administered intramuscularly,3 as they have been seen, likewise, in combined treatment with penicillin given by intramuscular injection and sodium iodide administered by oral and intravenous routes.4 Since, however, combined treatment with penicillin injected intramuscularly and tryparsamide administered intravenously has shown much less evidence of synergistic or additive chemotherapeutic effects,5 we have thought it advisable to determine whether or not combined treatment with bismuth compounds given by intramuscular injection and tryparsamide administered . . . [Full Text PDF of this Article]


Author Affiliations

Professor of Medicine, Temple University School of Medicine and School of Dentistry; Director of the Research Institute of Cutaneous Medicine; PHILADELPHIA

From the Research Institute of Cutaneous Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1950 American Medical Association. All Rights Reserved.